http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285199-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0636bdd1effca4dd96f96f6f393f37a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c54bfbd3f7dc53cbf0e6d08cc0b970c9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-31 |
| filingDate | 2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e59a5358e408029fca788ba8cacfb31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfdc57f096b01198455433119fc36c1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5da05e2386254b70d487b3d6839fc73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2281d70f7b837ade212c690038a8df3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5d0f34e96e8b5fc6d23ddff5ea360a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_281ac94758f4eb0a41a9561e3bb21bad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d3486f89672d43c22b2fff955af322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6250ee0ca1ee1c6eb179be7b014fd98c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82f2d35e73a5335dd2b4aac3d7a6bd08 |
| publicationDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-11285199-B2 |
| titleOfInvention | Vaccine composition comprising recombinant protein of Staphylococcus aureus attenuated enterotoxin and cytotoxin |
| abstract | The present invention relates to a vaccine composition comprising a Staphylococcus aureus attenuated enterotoxin protein and cytotoxin protein, and more particularly to a Staphylococcus aureus enterotoxin protein, a Staphylococcus aureus cytotoxin protein, a vaccine composition for prevention of bovine mastitis, comprising the Staphylococcus aureus enterotoxin protein and Staphylococcus aureus cytotoxin protein and a method for preventing bovine mastitis comprising administering the vaccine composition to a bovine. The Staphylococcus aureus enterotoxin protein, the Staphylococcus aureus cytotoxin protein according to the present invention, and the vaccine composition comprising the proteins as an antigen can be used so that even vaccines comprising several antigens rather than all kinds of antigens show the excellent effects of prevention and treatment of bovine mastitis against all kinds of Staphylococcus aureus enterotoxin and cytotoxin having high incidence in Korea, thereby being more economically used for industrial purposes. Further, the vaccine composition for prevention of bovine mastitis, comprising the Staphylococcus aureus enterotoxin protein and Staphylococcus aureus cytotoxin protein according to the present invention has an excellent safety and bovine mastitis prevention and treatment effect even in the high CFU Staphylococcus aureus challenge test so that the composition can be variously utilized in Staphylococcus aureus vaccine and prevention related fields in future. |
| priorityDate | 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.